Skip to main navigation Skip to search Skip to main content

Treatment for diabetic nephropathy: Angiotensin receptor blockers preferred to angiotensin-converting enzyme inhibitors

  • Ilana Harman-Boehm

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)296-298
Number of pages3
JournalIsrael Medical Association Journal
Volume6
Issue number5
StatePublished - 1 May 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Angiotensin receptor blockers
  • Angiotensin-convering inhibitors
  • Diabetic nephropathy

ASJC Scopus subject areas

  • General Medicine

Cite this